31.     Pluttzky J: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001; 88:10k.

32.      Cabadés A, De los Reyes M, Abeytúa M, Fernández C, eds. Infarto agudo de miocardio. Barcelona Ed. Doyma, 1994; 6-26.

33.     Rev Med IMSS 2004; 42(1): 61-67.

34.     Abramson JH. Prevention of cardiovascular disease in the elderly. Public Health Rev 2005; 13: 165-223.

35.     Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J Hum Hypertens 2000; 12: 575-81.

36.      Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis Circulation 2003; 105:1135.

37.     Vega F LF. Trombolisis Prehospitalaria. Trabajo Para Optar por el Título de Especialista en Cardiología. Medicentro. VC. 2002.

38.      Ministerio de Salud y Desarrollo Social. Republica Bolivariana de Venezuela. Anuario nacional de Estadística. 2005. Tasas

39.      Fleming A. Twentieth-century changes in the treatment of septic infections. N Engl J Med. 1953;248:1037-45.

40.   Paneth N. Assessing the contributions of John Snow to epidemiology: 150 years after removal of the broad street pump handle. Epidemiology. 2004;15:514-6.

41.    Keys A. . Atherosclerosis: a problem in newer Public Health. J Mt Sinai Hosp. 1953;20:118-39.

42.    Dawber TR, Meadors GF, Moore FEJ. . Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1989;41:279-86.

43.   Splansky GL, Corey D, Yang Q, Arwood LD, Cupples LA, Benjamin EJ, et al. The third generation cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination. Am J Epidemiol. 2007;165:1328-35.

44.    ODonnell Christopher J Elosua R.; Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study; Vol. 61; 2008;299-307.

45.    Domínguez Fernández J. M. Prevalencia de Factores de Riesgo Cardiovascular en una población Bicultural; Instituto Nacional de Gestión Sanitaria. Ceuta;2005; 6-14.

46.    McNamara J. J., Molot M. A., Stremple J. F. et al. 1991.Coronary artery disease in combat casualties in Vietnam. Journal of American Medical Association 216, 1185.

47.   Rodríguez F, Villar F, Banegas J. Epidemiología de las enfermedades cardiovasculares y de sus factores de riesgo en España. Madrid: Universidad Autónoma de Madrid. Facultad de Medicina. Departamento de Medicina Preventiva y Salud Pública. http://www. se arteriosclerosis. org/ aula_se arteriosclerosis/ Tema 1/ epidemiologia. html.

48.   Del Rey J. Método epidemiológico y salud de la comunidad. Madrid: Interamericana, McGraw - Hill, 2004. Lakatia EG. Cardiovascular aging research: The next horizons.

49.   J Am Geriatr Soc 2001:47;613-625. 11.ECEHA: Estudio Cooperativo Español de Hipertensión

50.   Strand, B. H. y Tverdal, A. 2004. Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50, 000 Norwegian men and women. Journal Epidemiology and Community Health, Aug, 58(8), 705-709.

51.   Programa Nacional de Estadísticas de Salud. Egresos de establecimientos oficiales por diagnósticos. Ministerio de Salud y Acción Social, Buenos Aires, República Argentina. Serie 4, nº 18, 2002.

52.   What are the important components of a hearthealthy diet?. General Guidelines Cholesterol, Other Lipids, and Lipoproteins; Angina and Coronary Artery Disease and High Blood Pressure. March 2000. Disponible en http://www. healthandage. com/ Home/ gm%3D2 0%2 gsq% 3 Ddiet 21gid  6=4302

53.   National Cholesterol Education Program 1993: Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. National Institute of Health. Circulation 1994; 89: 1336-1345.

54.   RUSSEL RM, SALTZMAN E, RASMUSSEN H: Comparison of diet claims. Disponible en. http:// www healthandage. com/ Home/gm %3D20 %21gs q% 3Dd iet%2 1gid2=355.

55.   RUSSEL RM, LICHTENSTEN AH: Guidelines for dietary treatment. Current issues related to diet andcardiovascular disease. Disponible en: http:// www. health and age. com/html/ well_connected/ pdf/ doc23. pdf.

56.   León, M. “Bioquímica Bases para la Actividad Física”, Editorial “Deportes”, C. de la Habana, 2004.

57.   Boletín de la Sociedad Peruana de Medicina Interna - Vol. 13 Nº1 – 2003.

58.   World Health Organization. Managing the global epidemic of obesity. Geneva: WHO, 2005.

59.   Albert, J. y Torres Pont J. 2005 Obesidad, factores de riesgo. Estudio de prevalencia 2003 en el ámbito de un Ayuntamiento. Revista de la Sociedad Española de Salud Laboral. Admón. Pub. Vol I nº 11.Enero-Junio.

60.    RUBIN SM, SIDNEY S, BLACK DM: High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 2002; 113: 916-920.

61.   HARRIS T, COOK EF, GOLDMAN L: Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older: The Framingham Heart Study. J Am Geriatr Soc 2004; 36: 1023-1028.

62.   Lasses y Ojeda LA, Torres Gutiérrez JA, Salazar E. Dislipidemia en el anciano. Arch Cardiol Mex 2004; 74(4):315-26.

63.   Chen ML, Wang S, Dong J, Zeng P, Hou LW: A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Chin Med J (Engl). 2004;117(2):163-7.

64.   WEVERLING-RIJNSBURGER AWE, IRIS JONKERS IJAM, VAN EXEL E, GUSSEKLOO J, WESTENDORP RGJ: High-density vs low-density lipoprotein cholesterol as risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003; 163: 1549-1554.

65.   González LM, Morera Castro Y, Alvarez Publes N. Infarto del miocardio y metabolismo lipídico. Rev Cubana. 2004, 134-138.

66.   Associations of high-density lipoprotein subclasses and apolipoproteins with ischaemic heart disease and coronary atherosclerosis. American Heart Journal, 2004, 113, 589-597.

67.   Miller NE., Forde OH., Thelle DS., Mjos OD. The Tromso Heart Study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet, 2001, 956- 961.

68.   Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72 [fe de errores en: JAMA. 2003;290:197].

69.   Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. . Age-specific relevance of usual blood pressure to vascular mortality. Lancet. 2002; 360:1903-13.

70.   Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007;Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea de Hipertensión (ESH) y de la Sociedad Europea de Cardiología (ESC).

71.   Chobanian AV, Bakris GL, Black HR, Cushman WC, GreenLA, Izzo L Jr, et al, National Heart, Lung, Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. GL.

72.   Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:1003-10. OS.

73.   Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2003;358:1682-6. OS.

74.   Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2003;345:1291-7. OS.

75.   Mancia G, Grassi G. European, American and British Guidelines: similarities and differences. En: Black HR, Elliott WJ, editors. Hypertension. A companion to Braunwald’s Heart diseases. Amsterdam: Saunders-Elsevier; 2007. p. 571-5.

76.    McGruder et al. (2004). Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 2002 to 2003. Stroke. Jul, 35(7), 1557-1561.

77.   Illán Mayano J, Pérez Millán J, Gil Gregorio P. Electrocardiograma en el paciente geriátrico hospitalizado. Rev Esp Geriatr Gerontol 1986;21(2):77-88.

78.   Mihalick MJ, Fisch C. Electrocardiographic finding in the aged. Am Heart J.  1974;87:117-20.

79.   Campbell A, Caird FJ, Jackson FM. Prevalence of abnormalities of electrocardiogram in old people. Am Heart J 2003; 86:1005-8.

80.   López Serrano H, Pesquisa Electrocardiográfica en Pacientes De Edad Avanzada; Policlínico Docente José Martí; Medisan 2002:1(2):14-19.

81.   Pasini V. Aspectos electrocardiográficos en Idosos Arq Bras Cardiol 2002; 38(2):857.

82.   Harris R. The management of geriatric cardiovascular disease. Philadelphia. Toronto:J. B. Lippincot Company 1970:45-6.

83.   Torres Ruiz JB, Padovani Cantón A, Hernández Simon G, Fulladolsa Formcot A, Clemente Rodríguez ME, Osuna Herrera J. Alteraciones electrocardiográficas en ancianos. Rev Cubana Med 1986; 25:527-33.

84.   Jerone LF. The Merck Manual of Geriatrics Merck Sharp Dohme- Researc laboratories, 2001:370-80.